Sign in
4

Changes in Ownership

Travere Therapeutics, Inc. Filed Acc 0001209191-18-044489

Chief Medical Officer acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Rosenberg Noah L. · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2018-07-26 Grant or award : show line 1 in the form +10,000 10,000 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-07-26 Grant or award : show line 2 in the form Employee stock option (right to buy) +65,000 65,000 D
2018-07-26 Grant or award : show line 3 in the form Performance-based restricted stock units +10,000 10,000 D
Loading xslF345X03/doc4.xml…